Vinge has advised Apotea AB (publ) (“Apotea”) in connection with its listing on Nasdaq Stockholm. Th…
Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of shares whereby Xspray…
Priveq, a leading Nordic lower mid-market growth and buyout investor, has closed its seventh fund, P…
Vinge has advised Tobii AB (publ) in connection with a fully guaranteed rights issue of ordinary sha…
Vinge has advised Cell Impact AB (publ) in connection with a partly guaranteed rights issue which wi…
